麻豆传媒高清版

Eifiona is a Senior Research Fellow in Pharmacoeconomics at the Centre for Health Economics and Medicine Evaluation at 麻豆传媒高清版. She holds a Bachelors degree in Pharmacy from the University of Wales Institute of Science and Technology, Cardiff (1992) and in 2005 completed a Masters degree in Health Economics and Management at the University of Sheffield.聽

After graduating from Cardiff, Eifiona spent 8 years as a hospital pharmacist specialising in oncology, provision of clinical services, funding and business support in both the UK and Australia. Following on from this, Eifiona pursued a career in health economics within the pharmaceutical industry and the consulting environment, working on a wide range of projects including developing and adapting health economic models, budget impact models, cost of illness studies, HTA submissions, orphan drugs and environmental analyses.

She is experienced in a variety of therapy areas including oncology, neurology, respiratory, fertility and mental health. Eifiona also has widespread experience in the development of value communications, manuscripts and posters, and has co-authored peer-reviewed papers in health economics.聽

Eifiona joined CHEME in 2015 and is currently working on a range of pharmacoeconomic projects, including the NERVES trial on treatments for sciatica, the CF Start study in cystic fibrosis and the CASTLE study for聽children with rolandic epilepsy. She also undertakes peer-review of All Wales Medicines Strategy Group submissions and provides health economic support to the All Wales Therapeutics and Toxicology Centre.

• MSc: Health Economics and Management
  University of Sheffield, 2005
• BSc: Bachelor of Pharmacy
  University of Wales Institute of Science and Technology, Cardiff, 1992

2023

• Published
  Al-Najjar, N., Bray, L., Carter, B., Collingwood, A., Cook, G., Crudgington, H., Dietz, K., Hardy, W., Hiscock, H., Hughes, D., Morris, C., Rouncefield-Swales , A., Saron, H., Spowart, C., Stibbs-Easton, L., Tudur Smith, C., Watson, V., Whittle, L., Wiggs, L., Wood, E., Gringas, P. & Pal, D. K., 10 Mar 2023, In: BMJ Open. 13, 3, e065769.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review
• Published
  Pijeira Perez, Y., Wood, E. & Hughes, D., 1 Nov 2023, In: Orphanet Journal of Rare Diseases. 18, 1, 342.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review
• Published
  Carter, B., Bray, L., Al-Najjar, N., Tort Piella, A., Smith, C. T., Spowart, C., Collingwood, A., Crudgington, H., Currier, J., Hughes, D., Wood, E., Martin, R., Morris, C., Roberts, D., Rouncefield-Swales , A., Sutherland, H., Watson, V., Cook, G., Wiggs, L., Gringas, P. & Pal, D., 6 Feb 2023, In: Trials. 24, 1, 83.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2021

• Published
  Wilby, M. J., Best, A., Wood, E., Burnside, G., Bedson, E., Short, H., Wheatley, D., Hill-McManus, D., Sharma, M., Clark, S., Bostock, J., Hay, S., Baranidharan, G., Price, C., Mannion, R., Hutchinson, P. J., Hughes, D., Marson, A. & Williamson, P. R., Apr 2021, In: Health Technology Assessment. 25, 24, 86 p.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review
• Published
  Wilby, M. J., Best, A., Wood, E., Burnside, G., Bedson, E., Short, H., Wheatley, D., Hill-McManus, D., Sharma, M., Clark, S., Baranidharan, G., Price, C., Mannion, R., Hutchinson , P. J., Hughes, D., Marson, A. G. & Williamson, P., 1 May 2021, In: The Lancet Rheumatology. 3, 5, p. e347-e356
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2020

• Published
  Wood, E. & Hughes, D., Jan 2020, In: PharmacoEconomics. 38, 1, p. 1-4
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2019

• Published
  Ramanan, A. V., Dick, A. D., Jones, A. P., Hughes, D., McKay, A., Rosala_Hanna, A., Williamson, P. R., Hardwick, B., Hickey, H., Rainford, N., Kolamunnage-Dona, R., Culeddu, G., Plumpton, C., Wood, E., Compeyrot-Lacassagne, S., Woo, P., Eldesten, C. & Beresford, M. W., 10 Apr 2019, In: Health Technology Assessment. 23, 15, p. 1-174 174 p.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review
• Published
  Hughes, D. A., Culeddu, G., Plumpton, C. O., Wood, E., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot Lacassagne, S., Hardwick, B., Hickey, H., Woo, P., Beresford, M. W. & Ramanan, A. V., Mar 2019, In: Ophthalmology. 126, 3, p. 415-424
  Research output: Contribution to journal 鈥� Article 鈥� peer-review
• Published
  Hughes, D., Culeddu, G., Plumpton, C., Wood, E., Dick, A. D., Beresford, M. W. & Ramanan, A. V., Mar 2019, In: Ophthalmology. 126, 3, p. e24-e25
  Research output: Contribution to journal 鈥� Letter 鈥� peer-review

2018

• Published
  Williams, N., Jenkins, A., Goulden, N., Hoare, Z., Hughes, D., Wood, E., Foster, N. E., Walsh, D. A., Carnes, D., Sparkes, V., Hay, E. M., Isaacs, J., Konstantinou, K., Morrissey, D., Karppinen, J., Genevay, S. & Wilkinson, C., 31 Jul 2018, In: Trials. 19, 408.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2017

• Published
  Williams, N. H., Jenkins, A., Goulden, N., Hoare, Z., Hughes, D. A., Wood, E., Foster, N. E., Walsh, D. A., Carnes, D., Sparkes, V., Hay, E. M., Isaacs, J., Konstantinou, K., Morrissey, D., Karppinen, J., Genevay, S. & Wilkinson, C., 31 Oct 2017, In: Health Technology Assessment. 21, 60, p. 1-180 180 p.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2016

• Published
  Hughes, D., Charles, J. M., Dawoud, D. M., Edwards, R. T., Holmes, E. A., Jones, C. L., Parham, P., Plumpton, C., Ridyard, C. O., Lloyd-Williams, H., Wood, E. M. & Yeo, S., May 2016, In: Pharmacoeconomics. 34, 5, p. 447-461
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2015

• Published
  Hughes, D., Tuersley, L. V., Hughes, D. A., Wood, E. M. & Tuersley, L., 19 May 2015, In: BMJ. 350
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2011

• Published
  Lowin, J., Bergman, A., Chaudhuri, K. R., Findley, L. J., Roeder, C., Schifflers, M., Wood, E. & Morris, S., 6 Jul 2011, In: Journal of Medical Economics. 14, 5, p. 584-93 10 p.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review
• Published
  Findley, L. J., Wood, E., Lowin, J., Roeder, C., Bergman, A. & Schifflers, M., 17 Jan 2011, In: Journal of Medical Economics. 14, 1, p. 130-9 10 p.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2010

• Published
  Asukai, Y., Valladares, A., Camps, C., Wood, E., Taipale, K., Arellano, J., Cassinello, A., Sacrist谩n, J. A. & Dilla, T., 29 Jan 2010, In: BMC Cancer. 10, p. 26
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2004

• Published
  Hind, D., Wyld, L., Wood, E., Beverley, C. & Reed, M. W., 19 Jul 2004, In: Cochrane Database of Systematic Reviews. 2004, 3, CD004561.
  Research output: Contribution to journal 鈥� Article 鈥� peer-review

2020

• The CASTLE study is focused on rolandic epilepsy, which is the most common type of childhood epilepsy and affects about one-sixth of all children with epilepsy in the UK.

  Throughout the CASTLE study, we鈥檒l be working with children, parents, doctors and nurses to choose the best ways to measure health and quality of life for children with epilepsy. The research will also include talking to parents and children about their experiences in relation to sleep, taking medication, learning and how taking part in the study has impacted on them.

  9 Mar 2020 鈥� 5 Dec 2023

  Links:

  Activity: Other (Contributor)

2019

• 13 Sep 2019

  Activity: Participation in Academic workshop, seminar, course (Speaker)

• 11 Jul 2019

  Activity: Participation in Academic workshop, seminar, course (Speaker)

• 2019 鈥� 2020

  Activity: Other (Contributor)

2018

• The aim of the CF START trial is determine the safest and most effective way to treat infants diagnosed with Cystic Fibrosis (CF) with antibiotics. At the moment infants in the UK are prescribed an antibiotic, usually flucloxacillin, every day to prevent infection with a bacteria (bug) called Staphylococcus aureus (SA).

  Although this approach appears to help prevent SA infection, there is a worry that it may make earlier infection with other bugs, such as Pseudomonas aeruginosa (PsA) more likely.

  This trial is designed to test if infants with CF are more likely to get an earlier infection from PsA if they are taking flucloxacillin on a daily basis (鈥淧revent and Treat鈥�) or Antibiotics in a more targeted manner (鈥淒etect and Treat鈥�).

  1 Sep 2018

  Links:

  Activity: Other (Contributor)

• 1 Aug 2018

  Activity: Other (Contributor)

• 6 Jul 2018

  Activity: Participation in Academic workshop, seminar, course (Speaker)

• 13 Apr 2018

  Activity: Participation in Academic workshop, seminar, course (Speaker)

• 2018 鈥� 2019

  Activity: Other (Contributor)

2017

• 2017 鈥� 2018

  Activity: Other (Contributor)

2016

• 1 Sep 2016 鈥� 1 Sep 2018

  Activity: Other (Contributor)

• 2016 鈥� 2107

  Activity: Other (Contributor)

2015

• 1 Mar 2015 鈥� 30 Sep 2019

  Links:

  Activity: Other (Contributor)

2013

• Deputy Health Economist, New Medicines Group

  2013 鈥� 2016

  Activity: Membership of committee (Member)